Mar 2, 2026 06:10AM
Mar 2, 2026 06:01AM
Mar 2, 2026 06:01AM
Feb 11, 2026 07:00AM
Jan 12, 2026 07:15AM
Jan 12, 2026 07:15AM
Jan 12, 2026 04:07AM Royalty Pharma provides up to $500 million for TEVA vitiligo drug
Jan 12, 2026 04:04AM
Jan 11, 2026 05:15PM
Jan 11, 2026 05:00PM
Dec 29, 2025 04:42PM
Dec 29, 2025 04:40PM
Dec 16, 2025 07:15AM
Dec 16, 2025 07:15AM Royalty Pharma Acquires Royalty Interest in Nuvalent’s Neladalkib and Zidesamtinib for Up to $315 Million
Dec 12, 2025 10:47AM
Dec 4, 2025 07:10AM
Dec 4, 2025 07:02AM
Dec 4, 2025 07:00AM
Nov 5, 2025 07:00AM
Nov 4, 2025 07:15AM
Nov 4, 2025 07:15AM Royalty Pharma Acquires Royalty Interest in Alnylam’s AMVUTTRA for $310 Million from Blackstone Life Sciences
Sep 2, 2025 07:15AM
Sep 2, 2025 07:15AM
Sep 2, 2025 07:05AM
Aug 25, 2025 06:10AM
Aug 25, 2025 06:10AM
Aug 25, 2025 06:10AM
Aug 6, 2025 07:00AM Royalty Pharma Reports Second Quarter 2025 Results
Jun 24, 2025 07:06AM
Jun 24, 2025 07:05AM
May 8, 2025 07:15AM
Apr 24, 2025 08:30AM
Apr 8, 2025 04:15PM
Apr 8, 2025 04:15PM
Feb 11, 2025 07:15AM Royalty Pharma Reports Q4 and Full Year 2024 Results
Jan 10, 2025 07:30AM
Nov 14, 2024 04:30PM
Nov 7, 2024 07:11AM
Nov 7, 2024 07:10AM
Nov 6, 2024 07:15AM
Nov 4, 2024 04:15PM
Nov 4, 2024 04:02PM Syndax Pharmaceuticals (SNDX) and Royalty Pharma (RPRX) Enter $350M Royalty Funding Agreement for Niktimvo
Nov 4, 2024 04:01PM
Sep 3, 2024 05:14PM
Sep 3, 2024 05:07PM
Sep 3, 2024 05:06PM
Aug 8, 2024 07:00AM
Jun 7, 2024 04:57AM
May 28, 2024 07:10AM Royalty Pharma plc (RPRX) and Agios Pharmaceuticals (AGIO) Enter Into Vorasidenib Royalty Agreement for $905 Million
May 28, 2024 07:10AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All